These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1119739)

  • 41. Interstitial lung disease. Assessment by bronchoalveolar lavage.
    Martin WJ; Williams DE; Dines DE; Sanderson DR
    Mayo Clin Proc; 1983 Nov; 58(11):751-7. PubMed ID: 6226835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of broncho-alveolar lavage in clinical pneumology and research].
    Junod AF
    Schweiz Med Wochenschr; 1986 Sep; 116(37):1235-8. PubMed ID: 3532314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system.
    Lehmann C; Wilkening A; Leiber D; Markus A; Krug N; Pabst R; Tschernig T
    Anat Rec; 2001 Nov; 264(3):229-36. PubMed ID: 11596005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary bacterial clearance and alveolar macrophage function in septic shock lung.
    Shennib H; Chiu RC; Mulder DS; Richards GK; Prentis J
    Am Rev Respir Dis; 1984 Sep; 130(3):444-9. PubMed ID: 6433760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitrofurantoin lung sensitivity: report of a case with prolonged nitrofurantoin lymphocyte sensitivity and interaction of nitrofurantoin-stimulated lymphocytes with alveolar cells.
    Pearsall HR; Ewalt J; Tsoi MS; Sumida S; Backus D; Winterbauer RH; Webb DR; Jones H
    J Lab Clin Med; 1974 May; 83(5):728-37. PubMed ID: 4595420
    [No Abstract]   [Full Text] [Related]  

  • 46. Pulmonary defence mechanisms.
    Nicod LP
    Respiration; 1999; 66(1):2-11. PubMed ID: 9973683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current ideas on some protective-adaptive mechanisms of the respiratory organ system in the light of aerosol (inhalation) immunization].
    Osipov VI; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):3-9. PubMed ID: 1266464
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunologic markers and fine structure of alveolar cells in germfree pigs.
    Trebichavský I; Mandel L; Vĕtvicka V
    Folia Biol (Praha); 1987; 33(4):246-52. PubMed ID: 3666236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung lymphocytes: origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders.
    Semenzato G; Bortolin M; Facco M; Tassinari C; Sancetta R; Agostini C
    Crit Rev Clin Lab Sci; 1996; 33(5):423-55. PubMed ID: 8922892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Jan; 118(1):146-50. PubMed ID: 830745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determination of macrophage activity in bronchoalveolar lavage fluid in patients with lung diseases].
    Ochendalski M; Müller S; Unger U; Grollmuss H; Schilling W
    Z Erkr Atmungsorgane; 1987; 168(1):19-24. PubMed ID: 3577241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immune protective mechanisms of the respiratory tracts].
    Treshchinskiĭ AI; Trotsevich VA
    Anesteziol Reanimatol; 1980; (3):36. PubMed ID: 6996529
    [No Abstract]   [Full Text] [Related]  

  • 54. Role of bronchoalveolar lavage in the investigation of cell-mediated defence mechanisms against lung cancer.
    Spatafora M; Merendino AM; Chiappara G; Melis M; Volpes D; Bellia V; Bonsignore G
    Eur Respir J; 1990 Mar; 3(3):370-1. PubMed ID: 2187710
    [No Abstract]   [Full Text] [Related]  

  • 55. Heterogeneity of immunologic function among subfractions of normal rat alveolar macrophages.
    Shellito J; Kaltreider HB
    Am Rev Respir Dis; 1984 May; 129(5):747-53. PubMed ID: 6609653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell content in repetitive canine bronchoalveolar lavage.
    Pinsker KL; Norin AJ; Kamholz SL; Montefusco C; Schreiber K; Hagstrom JW; Veith FJ
    Acta Cytol; 1980; 24(6):558-63. PubMed ID: 6934684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Nonspecific protective mechanisms of the respiratory tracts].
    Treshchinskiĭ AI; Trotsevich VA
    Anesteziol Reanimatol; 1979; (2):3-7. PubMed ID: 375775
    [No Abstract]   [Full Text] [Related]  

  • 58. Pulmonary host defense: coordinated interaction of mechanical, cellular and humoral immune systems of the lung.
    Kazmierowski JA; Aduan RP; Reynolds HY
    Bull Eur Physiopathol Respir; 1977; 13(1):103-16. PubMed ID: 300258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW; Muller WA; Cotran RS
    J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of cortisone treatment and burn injury on plasma and lung lavage cortisol concentrations and alveolar macrophage activity.
    Gudewicz PW; Ferguson JL; Kapin MA; Jaffe RC
    Adv Shock Res; 1981; 5():123-32. PubMed ID: 7304325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.